Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Releasing Control from Practitioner to Patient Through Technology

Releasing Control from Practitioner to Patient Through Technology

An interview with Sarah Fairbairn, Product Discovery Team Manager, LumiraDx, at the NHS Health and Care Innovation Expo, discussing the need for innovation in the NHS, and how LumiraDx were able to change the model of care for patients on anticoagulants.

What are the major challenges currently facing the NHS?

Obviously; money, capacity, resources to cope with an ageing population, but also the public’s expectations. People not only want to live longer and receive the best treatments available, but they also want instantaneous access to healthcare and information.

Medical records on tablet By Tero VesalainenImage Credit: Tero Vesalainen / Shutterstock

Just today I checked into my hotel using my phone, ordered online shopping and transferred a payment to someone. All from my mobile.

But when it comes to healthcare, we’re still lagging behind and people’s expectations are not being met. That’s the greatest challenge for the NHS right now; meeting the public’s expectations – how can managing your health be as easy as online banking?

How are cloud-based technologies transforming the medical industry?

For years, patient information sat within the hospital or GP’s own databases, not connected to any other care providers systems. This meant that it was extremely difficult for commissioners to assess the success of each service and compare it to other services in the UK.

You might have twenty anti-coagulation services in a single area, for example, and no way of comparing the care that each patient is receiving at those centers. With our population analytics you can see up-to-date data across all your anticoagulation services – that wouldn’t be possible without cloud-based technology.

Cloud-based technologies are about improving data accessibility. If the data is in the cloud, then it can be accessed by clinicians where and when they need it – for example if someone is on holiday in Cornwall, they can go to a clinic using INRstar and their full anticoagulation history can be pulled up.

If the data is in isolated pots all over the place, it can’t be accessed by the people who need it, so I think that cloud technology is transforming healthcare because it’s enabling the data to flow and become connected.

How have LumiraDx helped change the model of care for anticoagulation?

There are around 1 million people taking anticoagulants in the UK. Twenty years ago, you’d typically have your blood checked at a hospital clinic and then a junior doctor would work out what dose of blood thinner to prescribe you.

As you may imagine, this was resource intensive for the NHS and time-consuming for patients. There used to be lots of back and forth with referrals and laboratory results.

One of our founders was running one of these clinics and thought, “There must be a better way to do this”. So, he wrote a piece of software called INRstar, with built in algorithms to suggest the correct dosage of medication to give the patient.

The INRstar software helped change the model of care for patients on blood thinners. It meant that GPs no longer had to be so involved in the routine process, and nurses or healthcare assistants could take on much of the workload.

In the last few years we’ve moved into self-care; patients are able to carry out their own blood test on a portable coagulometer and using our engage app send the result to their care team.  They then receive the correct dose from their anticoagulation service who has processed it remotely. It saves nurse time and means less clinic visits for people.

ECG of irregular heartbeat - patient who needs anticoagulants - By Ocskay MarkImage Credit: Ocskay Mark / Shutterstock

What is health coaching, and how does it help patients manage their condition?

Health coaching is a great way of helping people understand their condition and motivating them to make key lifestyle changes that help them stay well. It is becoming a lot more accessible through the availability of wellbeing apps, which can be accessed by both the health coach and the patient.

Whenever you talk to patients who have long-term conditions, they often say that they have no control over their condition. This makes it really frightening and scary for them.

But through initiatives such as health coaching and motivational interviewing, you can help patients feel empowered, and they start to want to change their lifestyle, which can have a massive impact on their physical and mental health.

Health coaching is a hugely important piece of the puzzle, because so many of these long-term conditions have to do with lifestyle. However, GPs and nurses often don’t have the time to coach patients and this is where health apps can play a role.

Our self-care app includes short, easy to follow education videos which help people understand why anticoagulation is important as well as simple do’s and don’ts.

Being able to support patients outside of acute care is becoming increasingly difficult for doctors in today’s NHS. How are LumiraDx working to ease this?

The NHS needs to move towards a different model of care – making the most of digital technologies which can automate much of the routine work. It’s about enabling individuals to self-care as well as giving them access to care where and when they need it.

We need collaborative, connected care where responsibility and ownership of care is shared with the patient, with support when needed from the clinician.  

If individuals are able to access care in an easy and convenient way many hospital admissions could be avoided through providing the right treatment earlier.

We are building on our anticoagulation model and taking it into supporting long-term conditions, moving towards connected self-care which saves clinic time, is convenient and easy-to-use as well as improving health outcomes.

Where can readers find more information?

LumiraDx Care Solutions’ website

About LumiraDx

LumiraDx Care Solutions is the home of INRstar (an anticoagulant management tool) and engage (a supported self-care platform for patients). engage gives patients the knowledge, skills and confidence to self-care whilst staying connected with their care teams. Both INRstar and engage belong to the LumiraDx family.

Tagged with:

About author

Related Articles